Sage Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 106
EBIT TTM (mln): -373
index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 90 7 1,114 6 8 86 41
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% inf% -92.4% 16123.1% -99.4% 21.8% 1024.8% -52.3%
Marża brutto 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 94.2% 99.9% 91.2% 89.4% 97.5% 77.1%
EBIT (mln) -10 -18 -34 -95 -160 -273 -393 -708 596 -461 -547 -580 -432
EBIT Δ r/r 0.0% 89.8% 85.0% 179.9% 69.2% 70.5% 44.0% 80.1% -184.2% -177.3% 18.7% 6.0% -25.4%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -435.6% -10310.5% 53.5% -7306.7% -7116.7% -670.7% -1048.3%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 14 0 0
EBITDA (mln) -10 -18 -34 -95 -160 -273 -393 -708 652 -461 -547 -512 -409
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -435.6% -10310.5% 58.5% -7306.7% -7116.7% -591.9% -992.9%
Podatek (mln) 0 0 -0 -0 -1 -4 20 -30 16 -7 -30 -5 0
Zysk Netto (mln) -10 -18 -34 -94 -159 -270 -373 -650 606 -451 -503 -541 -401
Zysk netto Δ r/r 0.0% 89.8% 85.0% 179.5% 68.2% 69.9% 38.0% 74.4% -193.2% -174.4% 11.6% 7.6% -26.0%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -413.1% -9466.4% 54.4% -7146.9% -6547.8% -626.3% -971.5%
EPS -0.57 -1.09 -1.57 -3.4 -4.75 -7.09 -8.08 -12.79 11.66 -7.68 -8.49 -9.05 -6.59
EPS (rozwodnione) -0.39 -0.73 -1.57 -3.4 -4.75 -7.09 -8.08 -12.79 11.43 -7.68 -8.49 -9.05 -6.59
Ilośc akcji (mln) 17 17 22 28 33 38 46 51 52 59 59 60 61
Ważona ilośc akcji (mln) 25 25 22 28 33 38 46 51 53 59 59 60 61
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD